NuCana Plc (NCNA)
1.10
-0.03
(-2.65%)
USD |
NASDAQ |
Oct 09, 16:00
1.13
+0.03
(+2.73%)
After-Hours: 20:00
NuCana Cash from Operations (Quarterly) : -2.571M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.571M |
| March 31, 2026 | -4.087M |
| December 31, 2025 | -1.253M |
| September 30, 2025 | 1.579M |
| June 30, 2025 | -5.858M |
| March 31, 2025 | -3.880M |
| December 31, 2024 | -9.776M |
| September 30, 2024 | -5.766M |
| June 30, 2024 | -1.345M |
| March 31, 2024 | -7.302M |
| December 31, 2023 | 0.5243M |
| September 30, 2023 | -12.85M |
| June 30, 2023 | -7.260M |
| March 31, 2023 | -12.17M |
| December 31, 2022 | -7.378M |
| September 30, 2022 | 2.615M |
| June 30, 2022 | -11.24M |
| Date | Value |
|---|---|
| March 31, 2022 | -11.52M |
| December 31, 2021 | -13.60M |
| September 30, 2021 | -1.057M |
| June 30, 2021 | -6.825M |
| March 31, 2021 | -11.10M |
| December 31, 2020 | -11.79M |
| September 30, 2020 | -6.236M |
| June 30, 2020 | -1.578M |
| March 31, 2020 | -7.694M |
| December 31, 2019 | -4.294M |
| September 30, 2019 | -10.06M |
| June 30, 2019 | -6.832M |
| March 31, 2019 | -7.529M |
| December 31, 2018 | -2.716M |
| September 30, 2018 | -4.789M |
| June 30, 2018 | -4.039M |
| March 31, 2018 | -3.558M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -6.048M |
| BioNTech SE | 12.56M |
| Silence Therapeutics Plc | 1.548M |
| Compass Pathways Plc | -40.37M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0453M |
| Cash from Financing (Quarterly) | 0.0685M |
| Free Cash Flow | -6.612M |
| Free Cash Flow Per Share (Quarterly) | -0.625 |
| Free Cash Flow to Equity (Quarterly) | -2.611M |
| Free Cash Flow to Firm (Quarterly) | -2.616M |
| Free Cash Flow Yield | -148.4% |